We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Controlling Hypertension Outcomes by Improved Communication & Engagement
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Controlling Hypertension Outcomes by Improved Communication & Engagement
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement
Updated: 3/15/2016
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Updated: 3/16/2016
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Updated: 3/16/2016
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
Updated: 3/16/2016
Ultrasound Assessment of Muscle to Quantify Frailty.
Status: Enrolling
Updated: 3/16/2016
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
Updated: 3/16/2016
Ultrasound Assessment of Muscle to Quantify Frailty.
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Updated: 3/16/2016
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated: 3/16/2016
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Updated: 3/16/2016
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit
Updated: 3/16/2016
Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit
Status: Enrolling
Updated: 3/16/2016
Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit
Updated: 3/16/2016
Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Registry for Study of Coils in Intracranial Aneurysms
Updated: 3/17/2016
Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil (Gel-the-nec)
Status: Enrolling
Updated: 3/17/2016
Registry for Study of Coils in Intracranial Aneurysms
Updated: 3/17/2016
Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil (Gel-the-nec)
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
Updated: 3/17/2016
A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.
Status: Enrolling
Updated: 3/17/2016
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
Updated: 3/17/2016
A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Neuronal and Glial Biomarkers in Stroke
Updated: 3/17/2016
Neuronal and Glial Biomarkers in Stroke
Status: Enrolling
Updated: 3/17/2016
Neuronal and Glial Biomarkers in Stroke
Updated: 3/17/2016
Neuronal and Glial Biomarkers in Stroke
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Assistive Device Training in Multiple Sclerosis
Updated: 3/17/2016
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Status: Enrolling
Updated: 3/17/2016
Assistive Device Training in Multiple Sclerosis
Updated: 3/17/2016
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Updated: 3/18/2016
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Status: Enrolling
Updated: 3/18/2016
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Updated: 3/18/2016
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Treatment of Severe Childhood Aggression (The TOSCA Study)
Updated: 3/18/2016
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Updated: 3/18/2016
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Status: Enrolling
Updated: 3/18/2016
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Updated: 3/18/2016
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Updated: 3/18/2016
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Novel Stimulation Patterns for the Treatment of Dystonia
Updated: 3/18/2016
Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia
Status: Enrolling
Updated: 3/18/2016
Novel Stimulation Patterns for the Treatment of Dystonia
Updated: 3/18/2016
Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Safety Study for Adolescents With Concussion
Updated: 3/18/2016
Evaluation of the Safety of Exercise Testing With Acutely Concussed Adolescent Athletes
Status: Enrolling
Updated: 3/18/2016
Safety Study for Adolescents With Concussion
Updated: 3/18/2016
Evaluation of the Safety of Exercise Testing With Acutely Concussed Adolescent Athletes
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Updated: 3/21/2016
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials